share_log

A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals

クリネティックファーマシューティカルズについての11人のアナリストの推奨を詳しく見る

Benzinga ·  08/09 12:00

During the last three months, 11 analysts shared their evaluations of Crinetics Pharmaceuticals (NASDAQ:CRNX), revealing diverse outlooks from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings38000
Last 30D01000
1M Ago00000
2M Ago12000
3M Ago25000

Analysts have set 12-month price targets for Crinetics Pharmaceuticals, revealing an average target of $68.64, a high estimate of $97.00, and a low estimate of $54.00. This upward trend is evident, with the current average reflecting a 7.86% increase from the previous average price target of $63.64.

1723219246_0.png

Decoding Analyst Ratings: A Detailed Look

An in-depth analysis of recent analyst actions unveils...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする